0.1TWD
6.21 MTWD
1.76 BTWD
49.42 M
About BIONIME CORPORATION
Sector
Industry
CEO
Chun Mu Huang
Website
Headquarters
Taichung
Founded
2003
ISIN
TW0004737002
FIGI
BBG0015S6V78
Bionime Corp. engages in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. Its products include GE Max Series, GE GM550, GlucoCapture Wiz Series, GlucoCapture Cielo Series, GlucoCapture Oro SEries, GE 100, GE 200, GE333, Test Strips, and Lancing Device. The company was founded by Chun Mu Huang on April 14, 2003 and is headquartered in Taichung, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4737 is 69.0 TWD — it has increased by 0.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange BIONIME CORPORATION stocks are traded under the ticker 4737.
BIONIME CORPORATION is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
4737 stock is 0.87% volatile and has beta coefficient of 0.18. Check out the list of the most volatile stocks — is BIONIME CORPORATION there?
4737 earnings for the last quarter are 0.66 TWD per share, whereas the estimation was 0.60 TWD resulting in a 10.00% surprise. The estimated earnings for the next quarter are 0.40 TWD per share. See more details about BIONIME CORPORATION earnings.
BIONIME CORPORATION revenue for the last quarter amounts to 571.00 M TWD despite the estimated figure of 537.00 M TWD. In the next quarter revenue is expected to reach 487.00 M TWD.
Yes, you can track BIONIME CORPORATION financials in yearly and quarterly reports right on TradingView.
4737 stock has risen by 0.15% compared to the previous week, the month change is a 1.43% fall, over the last year BIONIME CORPORATION has showed a 6.88% decrease.
4737 net income for the last quarter is 11.45 M TWD, while the quarter before that showed −10.12 M TWD of net income which accounts for 213.19% change. Track more BIONIME CORPORATION financial stats to get the full picture.
Today BIONIME CORPORATION has the market capitalization of 4.19 B, it has decreased by 0.73% over the last week.
BIONIME CORPORATION dividend yield was 2.67% in 2023, and payout ratio reached 1.96 K%. The year before the numbers were 2.72% and 139.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4737 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONIME CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIONIME CORPORATION technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIONIME CORPORATION stock shows the sell signal. See more of BIONIME CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIONIME CORPORATION EBITDA is 150.08 M TWD, and current EBITDA margin is 8.55%. See more stats in BIONIME CORPORATION financial statements.